Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Seres Therapeutics, Inc. | 31,746 | reported | 05 Jul 2022 | tx 7+199,746 |
| Neon Therapeutics, Inc. | 0 | reported | 06 May 2020 | tx 4+18,500−72,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Jul 2022 | GRANT_AWARD | Seres Therapeutics, Inc. | 31,746 | 3.15 USD | |
| 22 Jun 2022 | GRANT_AWARD | Seres Therapeutics, Inc. | 35,000 | 0.00 USD | deriv |
| 22 Jun 2022 | GRANT_AWARD | Seres Therapeutics, Inc. | 35,000 | 0.00 USD | deriv |
| 16 Jun 2021 | GRANT_AWARD | Seres Therapeutics, Inc. | 23,000 | 0.00 USD | deriv |
| 18 Jun 2020 | GRANT_AWARD | Seres Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 06 May 2020 | OTHER | Neon Therapeutics, Inc. | 40,000 | — | deriv |
| 06 May 2020 | OTHER | Neon Therapeutics, Inc. | 14,000 | — | deriv |
| 06 May 2020 | OTHER | Neon Therapeutics, Inc. | 18,500 | — | deriv |
| 25 Jun 2019 | GRANT_AWARD | Neon Therapeutics, Inc. | 18,500 | 0.00 USD | deriv |
| 13 Jun 2019 | GRANT_AWARD | Seres Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 30 Aug 2018 | GRANT_AWARD | Seres Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |